Platelet density per Monocyte predicts adverse events in patients after Percutaneous coronary intervention

Thrombosis and Haemostasis

Volumn 115, Issue 2, 2016, Pages 353-360

  Rutten, Bert ^a   Roest, Mark ^a   McClellan, Elizabeth A ^b,d   Sels, Jan W ^c   Stubbs, Andrew ^b   Jukema, J Wouter ^d   Doevendans, Pieter A ^a   Waltenberger, Johannes ^e   Van Zonneveld, Anton Jan ^f   Pasterkamp, Gerard ^a   De Groot, Philip G ^a   Hoefer, Imo E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Adverse events; Monocytes; Percutaneous coronary intervention; Platelets

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN; VASCULOTROPIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; FLUORESCENT DYE; THROMBIN RECEPTOR;

ANTIBODY RESPONSE; ARTICLE; CELL CULTURE; CELL PHAGOCYTOSIS; CONTROLLED STUDY; ENDOTHELIUM; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONOCYTE; MYOFIBROBLAST; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; THROMBOCYTE ACTIVATION; VIDEO MICROSCOPY; ADVERSE EFFECTS; BLOOD; CELL SEPARATION; CHEMISTRY; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CYTOLOGY; FLUORESCENCE MICROSCOPY; KAPLAN MEIER METHOD; METABOLISM; PROCEDURES; PROPORTIONAL HAZARDS MODEL; THROMBOCYTE; THROMBOCYTE COUNT; UMBILICAL VEIN ENDOTHELIAL CELL;

BLOOD PLATELETS; CELL SEPARATION; COHORT STUDIES; CORONARY ARTERY DISEASE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; MICROSCOPY, FLUORESCENCE; MICROSCOPY, VIDEO; MONOCYTES; PERCUTANEOUS CORONARY INTERVENTION; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROPORTIONAL HAZARDS MODELS;

EID: 84957573817     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-03-0227     Document Type: Article

References (30)

1. Cuculi F, Lim C, Banning A. Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented? Heart 2010; 96: 736–740.
2. Ganesha Babu G, Malcolm Walker J, Yellon D, et al. Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Eur Heart J 2010; 32: 23–31.
3. Lansky A, Stone G. Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention. Circulation Cardiovasc Interven 2010; 3: 602–610.
4. Levitsky S. Protecting the Myocardial Cell During Coronary Revascularisation. Circulation 2006; 114: I-339-I-343.
5. Murray P, Wynn T. Protective and pathogenic functions of macrophage subsets. Nature Rev Immunol 2011; 11: 723–737.
6. Fujiyama S. Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1-Dependent Manner and Accelerate Reendothelialisation as Endothelial Progenitor Cells. Circulation Res 2003; 93: 980–989.
7. Moldovan N, Goldschmidt-Clermont P, Parker-Thornburg J, et al. Contribution of Monocytes/Macrophages to Compensatory Neovascularisation: The Drilling of Metalloelastase-Positive Tunnels in Ischaemic Myocardium. Circulation Res 2000; 87: 378–384.
8. Asahara T, Bauters C, Pastore C, et al. Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialisation and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery. Circulation 1995; 91: 2793–2801.
9. Nahrendorf M, Pittet M, Swirski F. Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction. Circulation 2010; 121: 2437–2445.
10. Nahrendorf M, Swirski F, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007; 204: 3037–3047.
11. Rehman J. Peripheral Blood “Endothelial Progenitor Cells“ Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors. Circulation 2003; 107: 1164–1169.
12. Urbich C. Relevance of Monocytic Features for Neovascularisation Capacity of Circulating Endothelial Progenitor Cells. Circulation 2003; 108: 2511–2516.
13. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularisation. Pro Natl Acad Sci 2000; 97: 3422–3427.
14. Rookmaaker M. Endothelial Progenitor Cells: Mainly Derived From the Monocyte/ Macrophage-Containing CD34– Mononuclear Cell Population and Only in Part From the Hematopoietic Stem Cell-Containing CD34+ Mononuclear Cell Population * Response. Circulation 2003; 108: 150e-150.
15. Davis C, Fischer J, Ley K, et al. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003; 1: 1699–1709.
16. Morrell C, Aggrey A, Chapman L, et al. Emerging roles for platelets as immune and inflammatory cells. Blood 2014; 123: 2759–2767.
17. Leppanen A, Yago T, Otto V, et al. Model Glycosulfopeptides from P-selectin Glycoprotein Ligand-1 Require Tyrosine Sulfation and a Core 2-branched O-Glycan to Bind to L-selectin. J Biol Chem 2003; 278: 26391–26400.
18. Huo Y, Ley K. Role of Platelets in the Development of Atherosclerosis. Trends Cardiovasc Med 2004; 14: 18–22.
19. Huo Y, Schober A, Forlow S, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2002; 9: 61–67.
20. da Costa Martins P. Platelet-Monocyte Complexes Support Monocyte Adhesion to Endothelium by Enhancing Secondary Tethering and Cluster Formation. Arterioscl Thromb Vasc Biol 2004; 24: 193–199.
21. Sixma J, de Groot P, van Zanten H, et al. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res 1998; 92: S43-S46.
22. Hoefer I, Sels J, Jukema J, et al. Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study. Clin Res Cardiol 2013; 102: 847–856.
23. Hoefer I. Arteriogenesis Proceeds via ICAM-1/Mac-1– Mediated Mechanisms. Circulation Res 2004; 94: 1179–1185.
24. Zhang Y, Liu D, Chen X, et al. Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration. Mol Cell 2010; 39: 133–144.
25. Heil M, Ziegelhoeffer T, Pipp F, et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol 2002; 283: H2411-H2419.
26. Bernardo A, Bakk C, Nolasco L, et al. Platelets adhered to endothelial cellbound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Thromb Haemost 2005; 3: 562–570.
27. De Maeyer B, De Meyer S, Feys H, et al. The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo. J Thromb Haemost 2010; 8: 2305–2312.
28. Urra X, Villamor N, Amaro S, et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cerebral Blood Flow Metabol 2009; 29: 994–1002.
29. Wrigley BJ, Shantsila E, Tapp LD, et al. Increased formation of monocyte-platelet aggregates in ischaemic heart failure. Circulation Heart Fail 2013; 6: 127–135.
30. Passacquale G, Vamadevan P, Pereira L, et al. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PloS one 2011; 6: e25595.